1. Home
  2. TLIH vs PHIO Comparison

TLIH vs PHIO Comparison

Compare TLIH & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TLIH

Ten-League International Holdings Limited Ordinary Shares

N/A

Current Price

$0.41

Market Cap

11.8M

Sector

N/A

ML Signal

N/A

Logo Phio Pharmaceuticals Corp.

PHIO

Phio Pharmaceuticals Corp.

HOLD

Current Price

$1.10

Market Cap

12.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLIH
PHIO
Founded
1998
2011
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.8M
12.3M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
TLIH
PHIO
Price
$0.41
$1.10
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$10.67
AVG Volume (30 Days)
396.2K
360.2K
Earning Date
09-30-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.10
N/A
Revenue
$51,204,304.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.94
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.31
$0.97
52 Week High
$7.00
$9.79

Technical Indicators

Market Signals
Indicator
TLIH
PHIO
Relative Strength Index (RSI) N/A 34.21
Support Level N/A $1.04
Resistance Level N/A $1.20
Average True Range (ATR) 0.00 0.09
MACD 0.00 0.02
Stochastic Oscillator 0.00 15.53

Price Performance

Historical Comparison
TLIH
PHIO

About TLIH Ten-League International Holdings Limited Ordinary Shares

Ten-League International Holdings Ltd is a Singapore-based provider of turnkey project solutions. Its business consists of sales of heavy equipment and parts, heavy equipment rental and provision of engineering consultancy services to port, construction, civil engineering and underground foundation industries. It currently conducts its operations through its wholly-owned subsidiaries. The equipment it provides is organized into four categories based on their functions and application scenarios, namely, foundation equipment, hoist equipment, excavation equipment and port machinery. The company operates in Singapore and Other International Countries.

About PHIO Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.

Share on Social Networks: